CEO: Douglas A. Treco

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Ra Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system.


Key numbers

Market Capitalization:2220576600
Shares Outstanding: 47146000
Float: 38851840
Next Earning Date:
TTm EPS: -1.9886
TTm Dividend Rate:
200 days moving average:33.93
50 days moving average: 46.9
One day percent Change: 0.11



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,